Results 21 to 30 of about 31,766 (260)
Medication errors safety signals COVID-19-related Moroccan Pv database [PDF]
E3S Web of Conferences, 2021 On March 23, 2020, the Moroccan Ministry of Health issued a circular authorizing the off label use of hydroxychloroquine or chloroquine in combination with azythromycin as first-line treatment for all COVID-19 patients. The aim of this study is to detect,
Sefiani Houda +3 more
doaj +1 more source
Indian Journal of Pharmacology, 2010 Sir, Vaccines are among the safest tools of modern medicine that help in protecting against disease by inducing immunity. In all countries, routine immunization represents a fundamental service of the public health system, offering one of the most cost-effective methods of reducing morbidity and mortality among children less than five.
Budhiraja, Salil, Akinapelli, Raghuram
openaire +3 more sources
Vaccination process evaluation at COVID-19 vaccination centers in Lebanon: a national study
Journal of Pharmaceutical Policy and Practice, 2022 Background Upon the authorization of COVID-19 vaccines worldwide, national and international standards were developed to help integrate mass COVID-19 immunization campaigns into the healthcare network.
Abeer Zeitoun +7 more
doaj +1 more source
Vaccines, 2023 Although the safety profiles of mRNA COVID-19 vaccines (mRNA-1273 and BNT162b2) were evaluated in pre-authorization clinical trials, real-world data allow us to better define their benefit/risk ratio in the paediatric population.
Alessia Zinzi +7 more
doaj +1 more source
Безопасность и риск фармакотерапии, 2020 The Rules of Good Pharmacovigilance Practice of the Eurasian Economic Union oblige developers and marketing authorisation holders to implement a pharmacovigilance system that has to be described in the pharmacovigilance system master file (PSMF ...
N. G. Goloenko +5 more
doaj +1 more source
A Review of Pharmacovigilance [PDF]
West Indian Medical Journal, 2015 Pharmacovigilance supports safe and appropriate use of drugs. Spontaneous reporting of adverse drug reactions (ADRs) is an essential component of pharmacovigilance. However, there is significant underreporting of ADRs. Adverse drug reactions have become a major problem in developing countries.
J E, Campbell +2 more
openaire +2 more sources
SARS-CoV-2 Treatment: Current Therapeutic Options and the Pursuit of Tailored Therapy
Applied Sciences, 2021 One year on from the worldwide outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), medicine has made several steps towards increasing the therapeutic options against its treatment.
Gianmarco Marcianò +7 more
doaj +1 more source
Pharmacovigilance [Pharmacovigilance update]
, 2021 The main pharmacovigilance updates in 2020 are reviewed. Remdesivir in COVID-19: relatively safe but turns out to be less effective than expected. Hydroxychloroquine in COVID-19 : lack of efficacy and risk of arrhythmias. Cytokines storm in COVID-19: may impact pharmacokinetics. VEGF inhibitors: risk of aneurysm and artery dissection. Tofacitinib: dose-
Ekobena, P., Ivanyuk, A., Livio, F.
openaire +1 more source
Pharmacovigilance workflow in Europe and Italy and pharmacovigilance terminology [PDF]
International Journal of Clinical Pharmacy, 2018 AbstractThe terminology used in pharmacovigilance can cause confusion, because there are similar terms that describe different phenomena (e.g. adverse reactions, adverse drug reactions, and side effects). Incorrect use of terminology can have negative effects on the reporting of adverse drug reactions and on the interpretation of these reports.
Paolo Baldo +2 more
openaire +2 more sources
Pharmacovigilance of herbal medicine [PDF]
Journal of Ethnopharmacology, 2012 Pharmacovigilance is essential for developing reliable information on the safety of herbal medicines as used in Europe and the US. The existing systems were developed for synthetic medicines and require some modification to address the specific differences of medicinal herbs.
Shaw, Debbie +4 more
openaire +3 more sources